139 related articles for article (PubMed ID: 6251928)
1. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders.
Arató M; Rihmer Z; Felszeghy K
Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928
[No Abstract] [Full Text] [Related]
2. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotides in mental disorder.
Belmaker RH; Zohar J; Ebstein RP
Adv Cyclic Nucleotide Res; 1980; 12():187-98. PubMed ID: 6250353
[TBL] [Abstract][Full Text] [Related]
4. Who responds to prophylactic lithium therapy?
Abou-Saleh MT
Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
[TBL] [Abstract][Full Text] [Related]
5. Lithium in the prophylactic treatment of recurrent affective disorders.
Kua EH; Lee SL; Chee KT
Singapore Med J; 1982 Oct; 23(5):262-4. PubMed ID: 7157005
[No Abstract] [Full Text] [Related]
6. Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
Kaschka WP; Thürauf N; Mokrusch T; Korth M
Pharmacopsychiatry; 1988 Nov; 21(6):404-6. PubMed ID: 3244776
[No Abstract] [Full Text] [Related]
7. Partial inhibition by lithium of the epinephrine-stimulated rise in plasma cyclic GMP in humans.
Belmaker RH; Kon M; Ebstein RP; Dasberg H
Biol Psychiatry; 1980 Feb; 15(1):3-8. PubMed ID: 6244010
[TBL] [Abstract][Full Text] [Related]
8. Quality of interepisodic periods in patients with affective disorders under long-term lithium treatment.
Volk J; Müller-Oerlinghausen B
Pharmacopsychiatry; 1988 Nov; 21(6):426-7. PubMed ID: 3244784
[No Abstract] [Full Text] [Related]
9. Relationship between prophylactic effect of lithium therapy and family history of affective disorders.
Engström C; Aström M; Nordqvist-Karlsson B; Adolfsson R; Nylander PO
Biol Psychiatry; 1997 Sep; 42(6):425-33. PubMed ID: 9285078
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic treatment of mood disorders: cost effectiveness analysis comparing lithium and carbamazepine].
Dardennes R; Lafuma A; Watkins S
Encephale; 1999; 25(5):391-400. PubMed ID: 10598301
[TBL] [Abstract][Full Text] [Related]
11. The challenge of predicting response to stabilising lithium treatment. The importance of patient selection.
Grof P; Alda M; Grof E; Fox D; Cameron P
Br J Psychiatry Suppl; 1993 Sep; (21):16-9. PubMed ID: 8217062
[TBL] [Abstract][Full Text] [Related]
12. [The use of carbamazepine in affective disorders].
Beresewicz M
Psychiatr Pol; 1994; 28(4):455-66. PubMed ID: 7972553
[TBL] [Abstract][Full Text] [Related]
13. Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate.
Berrettini WH; Nurnberger JI; Hare TA; Simmons-Alling S; Gershon ES; Post RM
Biol Psychiatry; 1983 Feb; 18(2):185-94. PubMed ID: 6403063
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of the erythro-plasmatic ratio of lithium (author's transl)].
Braccini T; Darcourt G; Corti H; Lapalus P; Lavagna J; Myquel M
Acta Psychiatr Belg; 1980; 80(4):413-9. PubMed ID: 6116378
[TBL] [Abstract][Full Text] [Related]
15. Saliva for monitoring of patients with primary affective disorders.
Ben-Aryeh H; Laor R; Szargel R; Gutman D; Naon H; Pascal M; Hefetz A
Isr J Med Sci; 1984 Mar; 20(3):197-201. PubMed ID: 6427134
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of lithium in the prophylaxis of affective disorders].
Ezquiaga E; García-López A; Nieves P; Rodríguez-Salvanés F
Actas Esp Psiquiatr; 2000; 28(3):156-60. PubMed ID: 11000697
[TBL] [Abstract][Full Text] [Related]
17. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic lithium treatment: treatment response, and patient attitudes toward illness and treatment.
Schmidt S; Ludwig W; Seibold S; Greil W
Pharmacopsychiatry; 1988 Nov; 21(6):274-5. PubMed ID: 3244750
[No Abstract] [Full Text] [Related]
19. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Ghadirian AM; Annable L; Bélanger MC; Chouinard G
J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
[TBL] [Abstract][Full Text] [Related]
20. [Follow-up evaluation of the prophylactic effect of lithium carbonate in cyclothymia].
Strzelecka I
Psychiatr Pol; 1980; 14(4):421-2. PubMed ID: 7003633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
